Are you ready for an unforgettable adventure that makes a difference?

Building on the success of Climb for a Cure: Kilimanjaro (2019) and Annapurna (2023) - which together raised over $500,000 for CML research - the iCMLf is thrilled to announce the next chapter: Climb for a Cure 2026.

In February 2026, we will take on the Avenue of Volcanoes in Ecuador - a breathtaking high-altitude challenge through one of the most stunning landscapes in the world. Over seven days, participants will trek through Cotopaxi National Park, climb to awe-inspiring viewpoints, and push their limits alongside a passionate team of researchers, doctors, patients, and CML advocates - all united by a single goal: drive progress in CML research, treatment, and patient care.

Read more

It’s still time to share your experiences in the iCMLf Hepatitis B Virus (HBV) and CML Screening and Management Survey. Your input is invaluable, and we look forward to learning from your clinical practice.

This survey is a key initiative to address the risk of HBV reactivation in CML patients receiving TKI therapy. Since there are currently no comprehensive guidelines and recommendations on HBV screening and monitoring for CML patients on TKIs, the data collected will help bridge this gap and inform future recommendations.

Submissions are welcome until February 27th, 2025.

Read more